XML 75 R51.htm IDEA: XBRL DOCUMENT v3.21.2
Segments of Business and Geographic Areas - Sales By Segment Of Business (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Oct. 03, 2021
Sep. 27, 2020
Oct. 03, 2021
Sep. 27, 2020
Sales by segment of business        
Sales to customers $ 23,338 $ 21,082 $ 68,971 $ 60,109
Percent Change (as a percent) 10.70%   14.70%  
U.S.        
Sales by segment of business        
Sales to customers $ 11,963 11,086 $ 34,993 31,324
Percent Change (as a percent) 7.90%   11.70%  
International        
Sales by segment of business        
Sales to customers $ 11,375 9,996 $ 33,978 28,785
Percent Change (as a percent) 13.80%   18.00%  
Consumer Health        
Sales by segment of business        
Sales to customers $ 3,700 3,514 $ 10,978 10,435
Percent Change (as a percent) 5.30%   5.20%  
Consumer Health | U.S.        
Sales by segment of business        
Sales to customers $ 1,625 1,556 $ 4,987 4,853
Percent Change (as a percent) 4.50%   2.80%  
Consumer Health | International        
Sales by segment of business        
Sales to customers $ 2,075 1,958 $ 5,991 5,582
Percent Change (as a percent) 5.90%   7.30%  
Consumer Health | OTC        
Sales by segment of business        
Sales to customers $ 1,372 1,142 $ 3,854 3,639
Percent Change (as a percent) 20.10%   5.90%  
Consumer Health | OTC | U.S.        
Sales by segment of business        
Sales to customers $ 686 601 $ 1,960 1,917
Percent Change (as a percent) 14.00%   2.20%  
Consumer Health | OTC | International        
Sales by segment of business        
Sales to customers $ 686 541 $ 1,894 1,722
Percent Change (as a percent) 26.90%   10.00%  
Consumer Health | Skin Health/Beauty        
Sales by segment of business        
Sales to customers $ 1,124 1,149 $ 3,457 3,273
Percent Change (as a percent) (2.20%)   5.60%  
Consumer Health | Skin Health/Beauty | U.S.        
Sales by segment of business        
Sales to customers $ 569 572 $ 1,862 1,767
Percent Change (as a percent) (0.50%)   5.40%  
Consumer Health | Skin Health/Beauty | International        
Sales by segment of business        
Sales to customers $ 555 577 $ 1,595 1,506
Percent Change (as a percent) (3.80%)   5.90%  
Consumer Health | Oral Care        
Sales by segment of business        
Sales to customers $ 398 412 $ 1,240 1,204
Percent Change (as a percent) (3.30%)   3.00%  
Consumer Health | Oral Care | U.S.        
Sales by segment of business        
Sales to customers $ 150 164 $ 478 510
Percent Change (as a percent) (8.40%)   (6.20%)  
Consumer Health | Oral Care | International        
Sales by segment of business        
Sales to customers $ 248 248 $ 762 694
Percent Change (as a percent) 0.10%   9.90%  
Consumer Health | Baby Care        
Sales by segment of business        
Sales to customers $ 391 393 $ 1,167 1,110
Percent Change (as a percent) (0.30%)   5.20%  
Consumer Health | Baby Care | U.S.        
Sales by segment of business        
Sales to customers $ 95 91 $ 288 279
Percent Change (as a percent) 5.20%   3.30%  
Consumer Health | Baby Care | International        
Sales by segment of business        
Sales to customers $ 296 302 $ 879 831
Percent Change (as a percent) (2.00%)   5.80%  
Consumer Health | Women's Health        
Sales by segment of business        
Sales to customers $ 232 230 $ 684 664
Percent Change (as a percent) 0.80%   3.00%  
Consumer Health | Women's Health | U.S.        
Sales by segment of business        
Sales to customers $ 3 3 $ 9 10
Percent Change (as a percent) 20.10%   (5.70%)  
Consumer Health | Women's Health | International        
Sales by segment of business        
Sales to customers $ 229 227 $ 675 654
Percent Change (as a percent) 0.50%   3.10%  
Consumer Health | Wound Care/Other        
Sales by segment of business        
Sales to customers $ 182 189 $ 575 545
Percent Change (as a percent) (3.50%)   5.40%  
Consumer Health | Wound Care/Other | U.S.        
Sales by segment of business        
Sales to customers $ 122 125 $ 390 370
Percent Change (as a percent) (2.60%)   5.30%  
Consumer Health | Wound Care/Other | International        
Sales by segment of business        
Sales to customers $ 61 64 $ 186 175
Percent Change (as a percent) (5.20%)   5.80%  
PHARMACEUTICAL        
Sales by segment of business        
Sales to customers $ 12,994 11,418 $ 37,792 33,304
Percent Change (as a percent) 13.80%   13.50%  
PHARMACEUTICAL | U.S.        
Sales by segment of business        
Sales to customers $ 7,221 6,438 $ 20,536 18,619
Percent Change (as a percent) 12.20%   10.30%  
PHARMACEUTICAL | International        
Sales by segment of business        
Sales to customers $ 5,773 4,980 $ 17,256 14,685
Percent Change (as a percent) 15.90%   17.50%  
PHARMACEUTICAL | Immunology        
Sales by segment of business        
Sales to customers $ 4,250 3,789 $ 12,395 10,950
Percent Change (as a percent) 12.20%   13.20%  
PHARMACEUTICAL | Immunology | U.S.        
Sales by segment of business        
Sales to customers $ 2,771 2,558 $ 7,932 7,330
Percent Change (as a percent) 8.30%   8.20%  
PHARMACEUTICAL | Immunology | International        
Sales by segment of business        
Sales to customers $ 1,480 1,230 $ 4,464 3,619
Percent Change (as a percent) 20.30%   23.30%  
PHARMACEUTICAL | Immunology | REMICADE®        
Sales by segment of business        
Sales to customers $ 761 921 $ 2,426 2,846
Percent Change (as a percent) (17.40%)   (14.80%)  
PHARMACEUTICAL | Immunology | REMICADE® | U.S.        
Sales by segment of business        
Sales to customers $ 480 634 $ 1,508 1,852
Percent Change (as a percent) (24.30%)   (18.60%)  
PHARMACEUTICAL | Immunology | REMICADE® | U.S. Exports        
Sales by segment of business        
Sales to customers $ 47 78 $ 197 321
Percent Change (as a percent) (40.20%)   (38.70%)  
PHARMACEUTICAL | Immunology | REMICADE® | International        
Sales by segment of business        
Sales to customers $ 234 209 $ 721 673
Percent Change (as a percent) 12.20%   7.10%  
PHARMACEUTICAL | Immunology | SIMPONI / SIMPONI ARIA®        
Sales by segment of business        
Sales to customers $ 571 592 $ 1,717 1,667
Percent Change (as a percent) (3.30%)   3.00%  
PHARMACEUTICAL | Immunology | SIMPONI / SIMPONI ARIA® | U.S.        
Sales by segment of business        
Sales to customers $ 295 312 $ 840 840
Percent Change (as a percent) (5.30%)   0.00%  
PHARMACEUTICAL | Immunology | SIMPONI / SIMPONI ARIA® | International        
Sales by segment of business        
Sales to customers $ 276 280 $ 877 827
Percent Change (as a percent) (1.10%)   6.10%  
PHARMACEUTICAL | Immunology | STELARA®        
Sales by segment of business        
Sales to customers $ 2,378 1,947 $ 6,800 5,463
Percent Change (as a percent) 22.20%   24.50%  
PHARMACEUTICAL | Immunology | STELARA® | U.S.        
Sales by segment of business        
Sales to customers $ 1,569 1,313 $ 4,396 3,668
Percent Change (as a percent) 19.50%   19.90%  
PHARMACEUTICAL | Immunology | STELARA® | International        
Sales by segment of business        
Sales to customers $ 809 634 $ 2,404 1,795
Percent Change (as a percent) 27.70%   33.90%  
PHARMACEUTICAL | Immunology | TREMFYA®        
Sales by segment of business        
Sales to customers $ 537 327 $ 1,434 965
Percent Change (as a percent) 64.10%   48.50%  
PHARMACEUTICAL | Immunology | TREMFYA® | U.S.        
Sales by segment of business        
Sales to customers $ 376 222 $ 975 650
Percent Change (as a percent) 69.70%   50.10%  
PHARMACEUTICAL | Immunology | TREMFYA® | International        
Sales by segment of business        
Sales to customers $ 161 105 $ 459 316
Percent Change (as a percent) 52.50%   45.40%  
PHARMACEUTICAL | Immunology | OTHER IMMUNOLOGY        
Sales by segment of business        
Sales to customers $ 3 3 $ 18 9
Percent Change (as a percent) (26.40%)   91.60%  
PHARMACEUTICAL | Immunology | OTHER IMMUNOLOGY | U.S.        
Sales by segment of business        
Sales to customers $ 3 0 $ 15 0
PHARMACEUTICAL | Immunology | OTHER IMMUNOLOGY | International        
Sales by segment of business        
Sales to customers 0 3 $ 3 9
Percent Change (as a percent)     (68.60%)  
PHARMACEUTICAL | Infectious Diseases        
Sales by segment of business        
Sales to customers $ 1,389 864 $ 3,424 2,662
Percent Change (as a percent) 60.60%   28.60%  
PHARMACEUTICAL | Infectious Diseases | U.S.        
Sales by segment of business        
Sales to customers $ 679 413 $ 1,635 1,265
Percent Change (as a percent) 64.30%   29.20%  
PHARMACEUTICAL | Infectious Diseases | International        
Sales by segment of business        
Sales to customers $ 709 451 $ 1,788 1,397
Percent Change (as a percent) 57.20%   28.00%  
PHARMACEUTICAL | Infectious Diseases | COVID-19        
Sales by segment of business        
Sales to customers $ 502 0 $ 766 0
PHARMACEUTICAL | Infectious Diseases | COVID-19 | U.S.        
Sales by segment of business        
Sales to customers 270 0 421 0
PHARMACEUTICAL | Infectious Diseases | COVID-19 | International        
Sales by segment of business        
Sales to customers 233 0 346 0
PHARMACEUTICAL | Infectious Diseases | EDURANT® / rilpivirine        
Sales by segment of business        
Sales to customers $ 259 236 $ 764 716
Percent Change (as a percent) 9.60%   6.70%  
PHARMACEUTICAL | Infectious Diseases | EDURANT® / rilpivirine | U.S.        
Sales by segment of business        
Sales to customers $ 12 11 $ 31 33
Percent Change (as a percent) 8.40%   (4.80%)  
PHARMACEUTICAL | Infectious Diseases | EDURANT® / rilpivirine | International        
Sales by segment of business        
Sales to customers $ 247 226 $ 733 684
Percent Change (as a percent) 9.70%   7.20%  
PHARMACEUTICAL | Infectious Diseases | PREZISTA® / PREZCOBIX® / REZOLSTA® / SYMTUZA®        
Sales by segment of business        
Sales to customers $ 517 526 $ 1,568 1,615
Percent Change (as a percent) (1.70%)   (2.90%)  
PHARMACEUTICAL | Infectious Diseases | PREZISTA® / PREZCOBIX® / REZOLSTA® / SYMTUZA® | U.S.        
Sales by segment of business        
Sales to customers $ 380 379 $ 1,128 1,154
Percent Change (as a percent) 0.40%   (2.20%)  
PHARMACEUTICAL | Infectious Diseases | PREZISTA® / PREZCOBIX® / REZOLSTA® / SYMTUZA® | International        
Sales by segment of business        
Sales to customers $ 137 147 $ 440 461
Percent Change (as a percent) (7.10%)   (4.60%)  
PHARMACEUTICAL | Infectious Diseases | OTHER INFECTIOUS DISEASES        
Sales by segment of business        
Sales to customers $ 110 102 $ 325 331
Percent Change (as a percent) 7.80%   (1.80%)  
PHARMACEUTICAL | Infectious Diseases | OTHER INFECTIOUS DISEASES | U.S.        
Sales by segment of business        
Sales to customers $ 18 24 $ 55 79
Percent Change (as a percent) (26.00%)   (29.60%)  
PHARMACEUTICAL | Infectious Diseases | OTHER INFECTIOUS DISEASES | International        
Sales by segment of business        
Sales to customers $ 93 78 $ 270 252
Percent Change (as a percent) 18.30%   6.90%  
PHARMACEUTICAL | Neuroscience        
Sales by segment of business        
Sales to customers $ 1,689 1,605 $ 5,218 4,850
Percent Change (as a percent) 5.30%   7.60%  
PHARMACEUTICAL | Neuroscience | U.S.        
Sales by segment of business        
Sales to customers $ 835 759 $ 2,448 2,285
Percent Change (as a percent) 10.20%   7.20%  
PHARMACEUTICAL | Neuroscience | International        
Sales by segment of business        
Sales to customers $ 854 846 $ 2,770 2,565
Percent Change (as a percent) 0.80%   8.00%  
PHARMACEUTICAL | Neuroscience | CONCERTA® / methylphenidate        
Sales by segment of business        
Sales to customers $ 157 149 $ 489 469
Percent Change (as a percent) 4.50%   4.10%  
PHARMACEUTICAL | Neuroscience | CONCERTA® / methylphenidate | U.S.        
Sales by segment of business        
Sales to customers $ 35 43 $ 117 150
Percent Change (as a percent) (19.50%)   (22.10%)  
PHARMACEUTICAL | Neuroscience | CONCERTA® / methylphenidate | International        
Sales by segment of business        
Sales to customers $ 122 107 $ 372 319
Percent Change (as a percent) 14.20%   16.40%  
PHARMACEUTICAL | Neuroscience | INVEGA SUSTENNA® / XEPLION® / INVEGA TRINZA® / TREVICTA®        
Sales by segment of business        
Sales to customers $ 1,004 926 $ 2,994 2,688
Percent Change (as a percent) 8.50%   11.40%  
PHARMACEUTICAL | Neuroscience | INVEGA SUSTENNA® / XEPLION® / INVEGA TRINZA® / TREVICTA® | U.S.        
Sales by segment of business        
Sales to customers $ 648 585 $ 1,882 1,704
Percent Change (as a percent) 11.00%   10.40%  
PHARMACEUTICAL | Neuroscience | INVEGA SUSTENNA® / XEPLION® / INVEGA TRINZA® / TREVICTA® | International        
Sales by segment of business        
Sales to customers $ 355 341 $ 1,111 983
Percent Change (as a percent) 4.30%   13.00%  
PHARMACEUTICAL | Neuroscience | RISPERDAL CONSTA®        
Sales by segment of business        
Sales to customers $ 140 152 $ 452 475
Percent Change (as a percent) (8.40%)   (4.90%)  
PHARMACEUTICAL | Neuroscience | RISPERDAL CONSTA® | U.S.        
Sales by segment of business        
Sales to customers $ 71 70 $ 210 220
Percent Change (as a percent) 1.30%   (4.70%)  
PHARMACEUTICAL | Neuroscience | RISPERDAL CONSTA® | International        
Sales by segment of business        
Sales to customers $ 69 81 $ 242 254
Percent Change (as a percent) (16.70%)   (5.10%)  
PHARMACEUTICAL | Neuroscience | OTHER NEUROSCIENCE        
Sales by segment of business        
Sales to customers $ 388 377 $ 1,284 1,218
Percent Change (as a percent) 3.10%   5.50%  
PHARMACEUTICAL | Neuroscience | OTHER NEUROSCIENCE | U.S.        
Sales by segment of business        
Sales to customers $ 81 60 $ 239 210
Percent Change (as a percent) 34.70%   13.90%  
PHARMACEUTICAL | Neuroscience | OTHER NEUROSCIENCE | International        
Sales by segment of business        
Sales to customers $ 307 317 $ 1,045 1,008
Percent Change (as a percent) (2.90%)   3.70%  
PHARMACEUTICAL | Oncology        
Sales by segment of business        
Sales to customers $ 3,665 3,129 $ 10,770 8,933
Percent Change (as a percent) 17.10%   20.60%  
PHARMACEUTICAL | Oncology | U.S.        
Sales by segment of business        
Sales to customers $ 1,525 1,267 $ 4,364 3,623
Percent Change (as a percent) 20.30%   20.40%  
PHARMACEUTICAL | Oncology | International        
Sales by segment of business        
Sales to customers $ 2,140 1,862 $ 6,406 5,310
Percent Change (as a percent) 14.90%   20.60%  
PHARMACEUTICAL | Oncology | DARZALEX®        
Sales by segment of business        
Sales to customers $ 1,580 1,099 $ 4,378 2,937
Percent Change (as a percent) 43.70%   49.10%  
PHARMACEUTICAL | Oncology | DARZALEX® | U.S.        
Sales by segment of business        
Sales to customers $ 841 585 $ 2,302 1,540
Percent Change (as a percent) 43.70%   49.50%  
PHARMACEUTICAL | Oncology | DARZALEX® | International        
Sales by segment of business        
Sales to customers $ 739 514 $ 2,076 1,397
Percent Change (as a percent) 43.70%   48.60%  
PHARMACEUTICAL | Oncology | ERLEADA        
Sales by segment of business        
Sales to customers $ 344 206 $ 907 519
Percent Change (as a percent) 66.70%   74.70%  
PHARMACEUTICAL | Oncology | ERLEADA | U.S.        
Sales by segment of business        
Sales to customers $ 214 152 $ 578 407
Percent Change (as a percent) 40.50%   41.80%  
PHARMACEUTICAL | Oncology | ERLEADA | International        
Sales by segment of business        
Sales to customers $ 130 55 $ 329 112
PHARMACEUTICAL | Oncology | IMBRUVICA®        
Sales by segment of business        
Sales to customers $ 1,066 1,031 $ 3,307 3,011
Percent Change (as a percent) 3.50%   9.90%  
PHARMACEUTICAL | Oncology | IMBRUVICA® | U.S.        
Sales by segment of business        
Sales to customers $ 413 450 $ 1,311 1,329
Percent Change (as a percent) (8.30%)   (1.30%)  
PHARMACEUTICAL | Oncology | IMBRUVICA® | International        
Sales by segment of business        
Sales to customers $ 654 581 $ 1,996 1,682
Percent Change (as a percent) 12.60%   18.70%  
PHARMACEUTICAL | Oncology | ZYTIGA® / abiraterone acetate        
Sales by segment of business        
Sales to customers $ 548 590 $ 1,749 1,848
Percent Change (as a percent) (7.20%)   (5.40%)  
PHARMACEUTICAL | Oncology | ZYTIGA® / abiraterone acetate | U.S.        
Sales by segment of business        
Sales to customers $ 25 58 $ 96 284
Percent Change (as a percent) (57.00%)   (66.20%)  
PHARMACEUTICAL | Oncology | ZYTIGA® / abiraterone acetate | International        
Sales by segment of business        
Sales to customers $ 523 532 $ 1,653 1,564
Percent Change (as a percent) (1.80%)   5.70%  
PHARMACEUTICAL | Oncology | OTHER ONCOLOGY(1)        
Sales by segment of business        
Sales to customers $ 126 203 $ 428 619
Percent Change (as a percent) (37.60%)   (30.70%)  
PHARMACEUTICAL | Oncology | OTHER ONCOLOGY(1) | U.S.        
Sales by segment of business        
Sales to customers $ 32 21 $ 76 63
Percent Change (as a percent) 49.60%   21.00%  
PHARMACEUTICAL | Oncology | OTHER ONCOLOGY(1) | International        
Sales by segment of business        
Sales to customers $ 94 181 $ 352 556
Percent Change (as a percent) (48.00%)   (36.60%)  
PHARMACEUTICAL | Pulmonary Hypertension        
Sales by segment of business        
Sales to customers $ 868 749 $ 2,599 2,283
Percent Change (as a percent) 15.90%   13.90%  
PHARMACEUTICAL | Pulmonary Hypertension | U.S.        
Sales by segment of business        
Sales to customers $ 610 510 $ 1,778 1,541
Percent Change (as a percent) 19.70%   15.40%  
PHARMACEUTICAL | Pulmonary Hypertension | International        
Sales by segment of business        
Sales to customers $ 258 239 $ 821 742
Percent Change (as a percent) 7.90%   10.70%  
PHARMACEUTICAL | Pulmonary Hypertension | OPSUMIT®        
Sales by segment of business        
Sales to customers $ 458 392 $ 1,371 1,187
Percent Change (as a percent) 17.00%   15.50%  
PHARMACEUTICAL | Pulmonary Hypertension | OPSUMIT® | U.S.        
Sales by segment of business        
Sales to customers $ 299 244 $ 861 729
Percent Change (as a percent) 22.80%   18.20%  
PHARMACEUTICAL | Pulmonary Hypertension | OPSUMIT® | International        
Sales by segment of business        
Sales to customers $ 159 148 $ 510 458
Percent Change (as a percent) 7.40%   11.30%  
PHARMACEUTICAL | Pulmonary Hypertension | UPTRAVI®        
Sales by segment of business        
Sales to customers $ 309 260 $ 927 792
Percent Change (as a percent) 19.00%   17.10%  
PHARMACEUTICAL | Pulmonary Hypertension | UPTRAVI® | U.S.        
Sales by segment of business        
Sales to customers $ 265 226 $ 792 692
Percent Change (as a percent) 17.30%   14.60%  
PHARMACEUTICAL | Pulmonary Hypertension | UPTRAVI® | International        
Sales by segment of business        
Sales to customers $ 44 34 $ 135 100
Percent Change (as a percent) 30.40%   34.60%  
PHARMACEUTICAL | Pulmonary Hypertension | Other        
Sales by segment of business        
Sales to customers $ 101 97 $ 301 304
Percent Change (as a percent) 3.40%   (1.10%)  
PHARMACEUTICAL | Pulmonary Hypertension | Other | U.S.        
Sales by segment of business        
Sales to customers $ 47 40 $ 125 121
Percent Change (as a percent) 14.40%   2.80%  
PHARMACEUTICAL | Pulmonary Hypertension | Other | International        
Sales by segment of business        
Sales to customers $ 54 57 $ 176 183
Percent Change (as a percent) (4.40%)   (3.70%)  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other        
Sales by segment of business        
Sales to customers $ 1,133 1,281 $ 3,386 3,625
Percent Change (as a percent) (11.50%)   (6.60%)  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | U.S.        
Sales by segment of business        
Sales to customers $ 800 931 $ 2,379 2,574
Percent Change (as a percent) (14.00%)   (7.60%)  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | International        
Sales by segment of business        
Sales to customers $ 333 351 $ 1,007 1,052
Percent Change (as a percent) (5.10%)   (4.20%)  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | XARELTO®        
Sales by segment of business        
Sales to customers $ 636 630 $ 1,794 1,716
Percent Change (as a percent) 0.80%   4.50%  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | XARELTO® | U.S.        
Sales by segment of business        
Sales to customers $ 636 630 $ 1,794 1,716
Percent Change (as a percent) 0.80%   4.50%  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | XARELTO® | International        
Sales by segment of business        
Sales to customers $ 0 0 $ 0 0
Percent Change (as a percent) 0.00%   0.00%  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | INVOKANA® / INVOKAMET®        
Sales by segment of business        
Sales to customers $ 133 224 $ 443 578
Percent Change (as a percent) (40.30%)   (23.40%)  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | INVOKANA® / INVOKAMET® | U.S.        
Sales by segment of business        
Sales to customers $ 66 156 $ 249 405
Percent Change (as a percent) (57.40%)   (38.40%)  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | INVOKANA® / INVOKAMET® | International        
Sales by segment of business        
Sales to customers $ 67 68 $ 194 173
Percent Change (as a percent) (1.00%)   11.90%  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | PROCRIT® / EPREX®        
Sales by segment of business        
Sales to customers $ 112 132 $ 366 423
Percent Change (as a percent) (14.60%)   (13.40%)  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | PROCRIT® / EPREX® | U.S.        
Sales by segment of business        
Sales to customers $ 47 69 $ 168 215
Percent Change (as a percent) (30.90%)   (21.70%)  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | PROCRIT® / EPREX® | International        
Sales by segment of business        
Sales to customers $ 65 63 $ 198 208
Percent Change (as a percent) 3.10%   (4.70%)  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | Other        
Sales by segment of business        
Sales to customers $ 251 294 $ 783 908
Percent Change (as a percent) (14.80%)   (13.80%)  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | Other | U.S.        
Sales by segment of business        
Sales to customers $ 51 75 $ 168 238
Percent Change (as a percent) (32.60%)   (29.30%)  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | Other | International        
Sales by segment of business        
Sales to customers $ 200 219 $ 615 670
Percent Change (as a percent) (8.70%)   (8.30%)  
MEDICAL DEVICES        
Sales by segment of business        
Sales to customers $ 6,644 6,150 $ 20,201 16,370
Percent Change (as a percent) 8.00%   23.40%  
MEDICAL DEVICES | U.S.        
Sales by segment of business        
Sales to customers $ 3,117 3,092 $ 9,470 7,852
Percent Change (as a percent) 0.80%   20.60%  
MEDICAL DEVICES | International        
Sales by segment of business        
Sales to customers $ 3,527 3,058 $ 10,731 8,518
Percent Change (as a percent) 15.40%   26.00%  
MEDICAL DEVICES | Interventional Solutions        
Sales by segment of business        
Sales to customers $ 957 836 $ 2,952 2,153
Percent Change (as a percent) 14.50%   37.10%  
MEDICAL DEVICES | Interventional Solutions | U.S.        
Sales by segment of business        
Sales to customers $ 444 399 $ 1,353 1,019
Percent Change (as a percent) 11.10%   32.70%  
MEDICAL DEVICES | Interventional Solutions | International        
Sales by segment of business        
Sales to customers $ 513 437 $ 1,599 1,134
Percent Change (as a percent) 17.70%   41.10%  
MEDICAL DEVICES | Orthopaedics        
Sales by segment of business        
Sales to customers $ 2,093 2,083 $ 6,433 5,572
Percent Change (as a percent) 0.50%   15.40%  
MEDICAL DEVICES | Orthopaedics | U.S.        
Sales by segment of business        
Sales to customers $ 1,249 1,308 $ 3,821 3,427
Percent Change (as a percent) (4.50%)   11.50%  
MEDICAL DEVICES | Orthopaedics | International        
Sales by segment of business        
Sales to customers $ 843 774 $ 2,611 2,145
Percent Change (as a percent) 8.80%   21.70%  
MEDICAL DEVICES | Orthopaedics | HIPS        
Sales by segment of business        
Sales to customers $ 356 345 $ 1,105 908
Percent Change (as a percent) 3.30%   21.80%  
MEDICAL DEVICES | Orthopaedics | HIPS | U.S.        
Sales by segment of business        
Sales to customers $ 210 221 $ 654 564
Percent Change (as a percent) (5.30%)   15.90%  
MEDICAL DEVICES | Orthopaedics | HIPS | International        
Sales by segment of business        
Sales to customers $ 146 124 $ 451 344
Percent Change (as a percent) 18.80%   31.30%  
MEDICAL DEVICES | Orthopaedics | KNEES        
Sales by segment of business        
Sales to customers $ 316 308 $ 983 825
Percent Change (as a percent) 2.80%   19.20%  
MEDICAL DEVICES | Orthopaedics | KNEES | U.S.        
Sales by segment of business        
Sales to customers $ 184 205 $ 579 527
Percent Change (as a percent) (9.80%)   10.00%  
MEDICAL DEVICES | Orthopaedics | KNEES | International        
Sales by segment of business        
Sales to customers $ 131 102 $ 403 298
Percent Change (as a percent) 28.10%   35.40%  
MEDICAL DEVICES | Orthopaedics | TRAUMA        
Sales by segment of business        
Sales to customers $ 715 685 $ 2,157 1,892
Percent Change (as a percent) 4.20%   14.00%  
MEDICAL DEVICES | Orthopaedics | TRAUMA | U.S.        
Sales by segment of business        
Sales to customers $ 455 433 $ 1,352 1,194
Percent Change (as a percent) 5.30%   13.30%  
MEDICAL DEVICES | Orthopaedics | TRAUMA | International        
Sales by segment of business        
Sales to customers $ 260 253 $ 805 698
Percent Change (as a percent) 2.40%   15.20%  
MEDICAL DEVICES | Orthopaedics | SPINE, SPORTS & OTHER        
Sales by segment of business        
Sales to customers $ 705 745 $ 2,187 1,947
Percent Change (as a percent) (5.30%)   12.30%  
MEDICAL DEVICES | Orthopaedics | SPINE, SPORTS & OTHER | U.S.        
Sales by segment of business        
Sales to customers $ 400 449 $ 1,236 1,142
Percent Change (as a percent) (11.10%)   8.20%  
MEDICAL DEVICES | Orthopaedics | SPINE, SPORTS & OTHER | International        
Sales by segment of business        
Sales to customers $ 306 295 $ 952 805
Percent Change (as a percent) 3.50%   18.20%  
MEDICAL DEVICES | Surgery        
Sales by segment of business        
Sales to customers $ 2,405 2,152 $ 7,299 5,803
Percent Change (as a percent) 11.80%   25.80%  
MEDICAL DEVICES | Surgery | U.S.        
Sales by segment of business        
Sales to customers $ 948 913 $ 2,881 2,247
Percent Change (as a percent) 3.90%   28.20%  
MEDICAL DEVICES | Surgery | International        
Sales by segment of business        
Sales to customers $ 1,457 1,239 $ 4,418 3,556
Percent Change (as a percent) 17.60%   24.20%  
MEDICAL DEVICES | Surgery | ADVANCED        
Sales by segment of business        
Sales to customers $ 1,144 1,000 $ 3,430 2,723
Percent Change (as a percent) 14.60%   26.00%  
MEDICAL DEVICES | Surgery | ADVANCED | U.S.        
Sales by segment of business        
Sales to customers $ 440 421 $ 1,304 1,079
Percent Change (as a percent) 4.60%   20.90%  
MEDICAL DEVICES | Surgery | ADVANCED | International        
Sales by segment of business        
Sales to customers $ 705 579 $ 2,126 1,644
Percent Change (as a percent) 21.80%   29.30%  
MEDICAL DEVICES | Surgery | GENERAL        
Sales by segment of business        
Sales to customers $ 1,261 1,152 $ 3,869 3,080
Percent Change (as a percent) 9.40%   25.60%  
MEDICAL DEVICES | Surgery | GENERAL | U.S.        
Sales by segment of business        
Sales to customers $ 508 492 $ 1,577 1,168
Percent Change (as a percent) 3.30%   35.00%  
MEDICAL DEVICES | Surgery | GENERAL | International        
Sales by segment of business        
Sales to customers $ 752 660 $ 2,292 1,912
Percent Change (as a percent) 13.90%   19.90%  
MEDICAL DEVICES | Vision        
Sales by segment of business        
Sales to customers $ 1,189 1,081 $ 3,517 2,843
Percent Change (as a percent) 10.10%   23.70%  
MEDICAL DEVICES | Vision | U.S.        
Sales by segment of business        
Sales to customers $ 475 473 $ 1,414 1,160
Percent Change (as a percent) 0.60%   21.90%  
MEDICAL DEVICES | Vision | International        
Sales by segment of business        
Sales to customers $ 714 608 $ 2,103 1,683
Percent Change (as a percent) 17.40%   25.00%  
MEDICAL DEVICES | Vision | CONTACT LENSES / OTHER        
Sales by segment of business        
Sales to customers $ 882 830 $ 2,607 2,198
Percent Change (as a percent) 6.20%   18.60%  
MEDICAL DEVICES | Vision | CONTACT LENSES / OTHER | U.S.        
Sales by segment of business        
Sales to customers $ 359 375 $ 1,082 924
Percent Change (as a percent) (4.30%)   17.00%  
MEDICAL DEVICES | Vision | CONTACT LENSES / OTHER | International        
Sales by segment of business        
Sales to customers $ 522 455 $ 1,525 1,274
Percent Change (as a percent) 14.90%   19.80%  
MEDICAL DEVICES | Vision | SURGICAL        
Sales by segment of business        
Sales to customers $ 308 251 $ 910 645
Percent Change (as a percent) 22.70%   41.10%  
MEDICAL DEVICES | Vision | SURGICAL | U.S.        
Sales by segment of business        
Sales to customers $ 117 98 $ 333 236
Percent Change (as a percent) 19.60%   41.10%  
MEDICAL DEVICES | Vision | SURGICAL | International        
Sales by segment of business        
Sales to customers $ 191 $ 153 $ 577 $ 409
Percent Change (as a percent) 24.70%   41.10%